MusclePharm Corporation (OTCQB:MSLP)
MSLP's top management has extensive experience in the sports world and has harnessed this drive and focus into building a business to benefit its customers and help Fuel The Athlete Inside. Headquartered in Aurora, Colorado, MSLP is a fast-growing developer and manufacturer of safe, scientifically approved, nutritional supplements that are free of banned substances and tested by athletes. They are designed to help athletes, bodybuilders, weightlifters and fitness enthusiasts improve their performance. Each and every MSLP product is the end result of an advanced six-stage research and testing protocol involving the expertise of top nutrition scientists. In addition, the products have been field-tested by more than 100 elite professional athletes from the NFL, MMA, MLB and elsewhere. To date, MSLP has developed six products: ASSAULT, BATTLE FUEL, BULLET PROOF, COMBAT POWDER, RECON and SHRED MATRIX. Two additional products are due in stores in 2010. MSLP products offer up to twice as much of the active ingredients per serving as competing products and incorporate a proprietary mix of ingredients not available elsewhere. MSLP was founded in 2008 and is based in Aurora, Colorado.
MSLP , one of the fastest growing nutritional supplement companies in the United States with a proprietary formulation used in eight performance products, announces MuscleGel achieves NSF certification. In addition, MSLP's Recon and Assault nutritional products will be NSF certified within the coming months.
We are extremely pleased MusclePharm's MuscleGel is now NSF certified and look forward to Recon and Assault's future addition to the NSF's list of approved supplements, commented Brad Pyatt, MSLP's Chief Executive Officer. Our Chief Medical Researcher, Dr. Jeffery Stout, Ph.D. and his team of scientists, doctors, and top professional athletes were instrumental in achieving the NSF's certification of MuscleGel, Recon and Assault. These three products provide strong, unique opportunities for us to expand MusclePharm's distribution within the professional athletic community, including the MLB and NFL.
NSF International is an independent, not-for-profit organization that meets the growing demands of athletes, coaches and all those concerned about banned substances in sports supplements. NSF International created the new NSF Certified for Sport Program. This new NSF program is a focused solution designed to minimize the risk that a dietary supplement or sports nutrition product contains banned substances. This program is part of NSF's successful 60-year history of providing certification programs for food, water and consumer goods.
MLB, the MLB Player's Association, NFL, the NFL Player's Association, PGA, LPGA and the CCES have all chosen NSF's Certified for Sport program to help verify the products their athletes use are safer and free of banned substances. NSF GMP for Sport certification verifies that the facility, operations and ingredient sourcing are in compliance with GMP requirements via ongoing audits.
MSLP products are currently available in 1,200 of the top General Nutrition Centers (NYSE:GNC) in the United States, as well as Vitamin Shop. MSLP's award-winning products Assault, Battle Fuel, Bullet Proof, Combat Powder, Recon and Shred Matrixare also available online at gnc.com, bodybuilding.com, amazon.com and many other locations.
To learn more about visit: http://www.musclepharm.com
Bridge Bancorp, Inc. (Nasdaq:BDGE)
BDGE, the holding company for The Bridgehampton National Bank, announced the declaration of a quarterly dividend of $0.23 per share. The dividend will be payable on October 26, 2010 to shareholders of record as of October 12, 2010. BDGE continues its trend of uninterrupted dividends.
BDGE, a New York corporation, is a one bank holding company engaged in commercial banking and financial services through its wholly owned subsidiary, The Bridgehampton National Bank. With assets of nearly $1 billion, the Bank operates in markets throughout Suffolk County, New York and provides deposit and loan products and financial services through its full service branch network and electronic delivery channels. Title insurance services are offered through the Bank's wholly owned subsidiary, Bridge Abstract. The Bank currently operates 18 retail branches in Suffolk County, Long Island. New branches have opened in Center Moriches and Patchogue and our 19th branch will open in Deer Park in October.
BDGE operates as the holding company for The Bridgehampton National Bank that provides a range of commercial and consumer banking services in eastern Long Island, New York. BDGE provides a range of deposit products, including savings deposits, NOW accounts, money market deposits, certificates of deposit, demand deposits, and time deposits. BDGE's loan portfolio comprises commercial real estate loans, home equity lines of credit, construction loans, residential mortgages, real estate mortgage loans, financial and agricultural loans, and secured and unsecured commercial and consumer loans. BDGE also offers merchant credit and debit card processing, automated teller machines, cash management, lockbox processing, online banking, and remote deposit capture services, as well as safe deposit boxes and individual retirement accounts. In addition, BDGE operates as a broker of title insurance services. BDGE principally serves small businesses, municipal relationships, and consumer relationships in the towns of East Hampton, Southampton, Southold, and Riverhead of Suffolk County. As of June 30, 2010, BDGE operated 17 retail branches in Suffolk County, Long Island. BDGE was founded in 1910 and is headquartered in Bridgehampton, New York.
To learn more about BDGE visit: http://www.bridgenb.com
Hampton Roads Bankshares, Inc. (Nasdaq:HMPR)
HMPR, the holding company for Bank of Hampton Roads and Shore Bank, today announced the results of its September 28, 2010 meeting of shareholders. HMPR's shareholders approved all management proposals put forward by an overwhelming majority, including the proposals required to implement HMPR's recapitalization plan and $255 million private placement transactions (the "Private Placement").
HMPR's shareholders elected John A. B. "Andy" Davies, Jr. as a Class A director, to serve a one-year term. Shareholders elected the following Class C directors to serve three-year terms: Herman A. Hall, III, W. Lewis Witt, Robert R. Kinser, Jordan E. Slone, Jerry T. Womack, and Ollin B. Sykes.
HMPR's shareholders also approved the following matters at the meeting:
- The issuance of up to 800,000,000 shares of common stock at $0.40 per share under the Investment Agreements signed with participants in HMPR's Private Placement;
- The issuance of up to 25,000,000 shares of common stock in transactions that would allow holders of the Company's Series A and Series B preferred stock to exchange their shares for newly issued shares of common stock;
- The issuance of up to 60,000,000 shares of common stock upon the conversion of 80,347 shares of Series C-1 Mandatorily Convertible Noncumulative Nonvoting Preferred Stock, to be issued to the U.S. Department of the Treasury in exchange for its Series C preferred stock;
- An amendment to the terms of HMPR's Articles of Incorporation (the "Articles") to increase the Company's authorized common stock from 100,000,000 shares to 1,000,000,000 shares;
- An amendment to the Articles to change the designations of the Series A and Series B preferred stock to eliminate dividends, reduce the liquidation preference and redemption value and allow for conversion of such preferred stock into common stock;
- An amendment to the Articles to permit the Board of Directors to effect a reverse stock split of the Company's common stock. The reverse stock split will be at a ratio determined by the Company's Board of Directors, within a range of ten to thirty; and
- A proposal to allow shareholders to endorse or not endorse the compensation of HMPRs named executive officers as disclosed in HMPR's common shareholder proxy statement related to its 2010 annual meeting.
HMPR operates as the holding company for Bank of Hampton Roads (BOHR) and Shore Bank that provide community and commercial banking services primarily to individuals and businesses. HMPR operates a network of 72 ATM machines. HMPR was founded in 1961 and is based in Norfolk, Virginia.
To learn more about HMPR visit: http://www.bankofhamptonroads.com
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE) has received twenty five thousand dollars in cash and seventy five thousand free trading shares from a third party (Bishop Equity Partners) for (30) days of advertising for Muscle Pharm Corp. (OTCQB:MSLP).
Disclosure: No positions